Latest Alzheimers News

Family history of Alzheimer's affects functional connectivity(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, and this effect is detectable even in t...

Eisai Plans More Global Cost Cuts In Wake Of Loss Of Aricept PatentEisai says it plans additional cost cuts by the end of the current fiscal year March, 2013, as a result of the patent-expiration of Alzheimer’s disease drug Aricept (donepezil).

Immune system involved in removing Alzheimer's-causing substance in the brainRecent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.

First study to suggest that the immune system may protect against Alzheimer's changes in humansRecent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.

A Smell Test for Alzheimer's?Published studies to date support a link between decreased olfaction and dementia but fail to provide strong evidence that smell tests can be used to predict dementia. Medscape Medical News

UC San Diego researchers receive new CIRM funding(University of California - San Diego) Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine to conduct stem...

Stemedica International And Academic Partner Awarded Swiss Alzheimer’s And Stem Cell Research GrantStemedica International announced today that it was awarded a grant by the Swiss Commission for Technology and Innovation along with its academic partner, The École Polytechnique Fédérale de Lausanne (EPFL). The 584,522 CHF (approx. 620,000 USD) grant is focused on the use of EPFL’s advanced imaging capabilities along with Stemedica’s ischemic tolerant stem cells and stem cell f...

The search for the earliest signs of Alzheimer's(Medical Xpress) -- For the past five years, volunteers from the City of Berkeley and surrounding areas have come to Lawrence Berkeley National Laboratory to participate in an ongoing study that’s changing what scientists know about Alzheimer...

Elan says may get offer if drug data positive- chairmanDUBLIN, May 24 (Reuters) - Irish drugmaker Elan said it was possible that the company could receive a takeover offer if data due later this year on an experimental Alzheimer's drug Bapineuzumab is positive.

Great HealthWorks Announces New Study: Omega-3s May Benefit Brain Proteins Linked to Alzheimer’sAccording to a recent study published online in Neurology, Omega-3 fatty acids, like those found in Omega XL fish oil extract containing DHA and EPA from the New Zealand green-lipped mussel, may provide more benefits for elderly people suffering from Alzheimer’s. According to the study, Researchers for the Neurology study examined the health and...

Omega-3 fatty acids may provide more benefits for elderly people with Alzheimer'sAccording to a recent study published online in Neurology, Omega-3 fatty acids, like those found in Omega XL fish oil extract containing DHA and EPA from the New Zealand green-lipped mussel, may provide more benefits for elderly people suffering from...

Cooling down ADA Johns Hopkins University team has clinical proof-of-concept data for slowing the progression of Alzheimer's disease by reducing activity in the hippocampus with antiepileptic drugs. AgeneBio has licensed the IP and is…

In Alzheimer's Disease, Neuron-Nourishing Cells Appear To RetaliateWhen brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report. Amyloid is excreted by all neurons...

Locating ground zero(European Molecular Biology Laboratory) Scientists at EMBL Heidelberg have discovered exactly how cells called microglia detect the site of brain injury - a finding that paves the way for new medical approaches to conditions where microglia's ability...

Alzheimer's disease: A breach in the blood–brain barrierAlterations in brain blood vessels in mice precede the neural dysfunction associated with Alzheimer's disease. The finding highlights potential targets for drug development. See Letter p.512

US government sets out Alzheimer’s planHealth-agency budget windfall includes funding for two promising clinical trials.

Human testing to start on anti-Alzheimer’s drugAfter an announcement by federal officials approving clinical trials for the drug Crenezumab, researchers searching for a way to treat [...]

Astrocytes appear to retaliate against ADWhen brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.

Researchers to initiate Crenezumab clinical trial to treat Alzheimer'sAfter an announcement by federal officials approving clinical trials for the drug Crenezumab, researchers searching for a way to treat Alzheimer's Disease are gearing up for a rare study that will allow them to test a therapy for a genetically predes...

U.S. Government Sets Out Alzheimer's PlanFrom Nature magazine [More]

Scientists identify key mechanism in development of Alzheimer'sNew research by scientists at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM) demonstrates how dying or damaged brain cells release debris into the bloodstream and give rise to specific autoantibodies...

Big Trial Starting for Genentech's Alzheimer's DrugNew York Times | Genentech's new Alzheimer's drug trial will test the drug on 200 patients with a genetic mutation for early-onset disease (with half receiving placebo) and another 100 family members without the mutation.

Pathological aging brains contain the same amyloid plaques as Alzheimer's diseasePathological aging (PA) is used to describe the brains of people which have Alzheimer's disease (AD)-like pathology but where the person showed no signs of cognitive impairment whilst they were alive. New research, published in BioMed Central's open...

Mayo Clinic Alzheimer's researcher honored twice in a month(Mayo Clinic) At Mayo Clinic, the name Clifford Jack Jr., M.D., means cutting-edge imaging and Alzheimer's research.

Neuron-nourishing Cells Appear to Retaliate in Alzheimer’sWhen brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer’s disease, the astrocytes that normally nourish and protect them deliver a suicide package instead.

0 1 2 3 4 ›»

buy Alzheimers market research data and corporate reports now Advertisement